We observed that Hiltonol+++ (Hiltonol in combination with inhibitors of IL6, JAK2, STAT3) significantly suppressed the viability of lung cancer cells compared to Hiltonol alone (Figure 1B). Here, IL6 is linked to lung carcinoma.